Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension
Aletta E. Schutte, Tazeen H. Jafar, Neil R Poulter, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 2, pp. 381-409
Open Access | Times Cited: 79

Showing 26-50 of 79 citing articles:

Is the lower the better in finding the best practical blood pressure goal under antihypertensive treatment?
Peter M. Nilsson
Journal of Internal Medicine (2025)
Closed Access
The impact of the COVID-19 pandemic on the socioeconomic gradient of hypertension
Alexandre Vallée
Journal of Public Health Policy (2024) Vol. 45, Iss. 3, pp. 413-430
Closed Access | Times Cited: 3
ACHIEVE conference proceedings: implementing action plans to reduce and control hypertension burden in Africa
Paul Olowoyo, Anastase Dzudié, Akinkunmi Paul Okekunle, et al.
Journal of Human Hypertension (2024) Vol. 38, Iss. 3, pp. 193-199
Closed Access | Times Cited: 2
Digital hypertension, implementation hypertension, and internationalization - 3 pillars of Japanese Society of Hypertension 2024–2026 advancing hypertension science from Japan to the world in the information network era
K. Kario, Akira Nishiyama, Shigeru Shibata, et al.
Hypertension Research (2024) Vol. 48, Iss. 1, pp. 1-5
Open Access | Times Cited: 2
Sex differentials in the prevalence of behavioral risk factors and non-communicable diseases in adult populations of West Kazakhstan
Akmaral Baspakova, Anara Abitova, Nadiar M. Mussin, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Understanding and controlling the increasing burden of cardiovascular diseases in Africa
Paul Olowoyo, Pasquale Maffia, Tomasz J. Guzik, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 4, pp. e9-e13
Open Access | Times Cited: 1
Qualitative Assessment of a virtual cardiovascular medical education Program in Haiti: local physicians in-training experiences
Marwa Ilali, Virginie Clavel, Veronika Panagiotou, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Estudio de prevalencia, conocimiento y control de la hipertensión arterial en barrios vulnerables de Argentina
Walter G. Espeche, M. Marín, Carlos Romero, et al.
Hipertensión y Riesgo Vascular (2024) Vol. 41, Iss. 2, pp. 78-86
Closed Access | Times Cited: 1
Screening for hepatitis B in the Bronx West African community with a blood pressure cuff: a cohort study
Julie Nguyen, M. Fibi Rani Dr. J. Shashank, J Birnbaum, et al.
The Lancet Regional Health - Americas (2024) Vol. 35, pp. 100780-100780
Open Access | Times Cited: 1
Religious minority status and risk of hypertension in women: Evidence from Bangladesh
Biplab Datta, Sanjoy Kumar Chowdhury
Heliyon (2024) Vol. 10, Iss. 13, pp. e33428-e33428
Open Access | Times Cited: 1
Density functional theory and enzyme studies support interactions between angiotensin receptor blockers and angiotensin converting enzyme-2: Relevance to coronavirus 2019
Vasso Apostolopoulos, Nikitas Georgiou, Demeter Tzeli, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107602-107602
Open Access | Times Cited: 1
Twelve–year (2008–2019) trends in socioeconomic inequalities in cardiovascular risk factors in a Swiss representative survey of the general population
Carlos de Mestral, Giovanni Piumatti, Mayssam Nehme, et al.
Preventive Medicine Reports (2024) Vol. 45, pp. 102823-102823
Open Access | Times Cited: 1
Activation AMPK in Hypothalamic Paraventricular Nucleus Improves Renovascular Hypertension Through ERK1/2-NF-κB Pathway
Li-Yan Fu, Yu Yang, Rui-Juan Li, et al.
Cardiovascular Toxicology (2024) Vol. 24, Iss. 9, pp. 904-917
Closed Access | Times Cited: 1
Sustainable hypertension care – a new strategy for an expanding problem
Peter M Nilsson, Miriam Pikkemaat, Aletta E. Schutte
Journal of Hypertension (2024) Vol. 42, Iss. 11, pp. 1891-1894
Closed Access | Times Cited: 1
Hypertension: A Continuing Public Healthcare Issue
Samaneh Goorani, Somaye Zangene, John D. Imig
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 123-123
Open Access | Times Cited: 1
Sustainable hypertension care – How can it be achieved?
Peter M. Nilsson
Journal of Internal Medicine (2023) Vol. 294, Iss. 3, pp. 242-244
Open Access | Times Cited: 3
Evaluation of community-based care delivered by primary healthcare providers in management of hypertension in a rural area of West Bengal
Prianka Mukhopadhyay, Maumita De, Surajit Lahiri, et al.
Journal of Family Medicine and Primary Care (2023) Vol. 12, Iss. 8, pp. 1685-1691
Open Access | Times Cited: 2
Traditional Therapeutics and Potential Epidrugs for CVD: Why Not Both?
Lauren Rae Gladwell, Chidinma Ahiarah, Shireen Rasheed, et al.
Life (2023) Vol. 14, Iss. 1, pp. 23-23
Open Access | Times Cited: 2
Extemporaneous combination therapy with nebivolol/amlodipine for the treatment of hypertension: a real-world evidence study in Europe
Giovambattista Desideri, Riccardo Cipelli, V. Pégoraro, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 5, pp. 733-743
Open Access
Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication
Janis M. Nolde, Emily Atkins, Simone Marschner, et al.
Journal of Hypertension (2024) Vol. 42, Iss. 6, pp. 1009-1018
Closed Access
Polypill as a means of population pharmacological prevention of cardiovascular diseases
P. A. Lebedev, I. K. Petruhina, E. V. Paranina
Experimental and Clinical Gastroenterology (2024), Iss. 2, pp. 64-74
Open Access
Rising standards and applying guidelines in sub-Saharan cardiology: CardioTan 2024 Heart Team Africa
Delila Kimambo, Bartłomiej Guzik, Peter Kisenge
European Heart Journal (2024) Vol. 45, Iss. 24, pp. 2112-2113
Open Access
The epigenetic legacy of renin–angiotensin system inhibition in preventing hypertension
Ryszard Nosalski, Matteo Lemoli
Cardiovascular Research (2024) Vol. 120, Iss. 7, pp. 675-677
Open Access
Effect of motivational interviewing on lifestyle modification among patients with hypertension attending the family medicine clinics of Irrua Specialist Teaching Hospital, Irrua, Nigeria – A randomized controlled trial (MILMAPH Study)
Tijani Idris Ahmad Oseni, Afiong Oku, Ifeoma N Monye, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Combined vaccines against angiotensin II receptor type 1 and alpha 1D-adrenergic receptor for hypertension
Jiacheng Wu, Wu Zhi, Wenlong Kuang, et al.
Journal of Hypertension (2024) Vol. 42, Iss. 7, pp. 1184-1196
Closed Access

Scroll to top